Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells (Q81306325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

11

Akiyoshi Fukamizu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Hideki Kato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Junji Ishida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Katsumasa Nagano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Kaori Honjo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Takeshi Sugaya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Fumihiro Sugiyama

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ken-Ichi Yagami

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Toshiro Fujita

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Masaomi Nangaku

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

19 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

731-739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490898%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2008.42

7 January 2020

exact match

0 references

cites work

Exploring type I angiotensin (AT1) receptor functions through gene targeting.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Use of angiotensin II receptor blockers in animal models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Role of the renin-angiotensin system in vascular diseases: expanding the field.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II type 1 receptor-mediated peroxide production in human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Activation of human peripheral monocytes by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Immunosuppressive treatment protects against angiotensin II-induced renal damage

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Control of dendritic cell differentiation by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

An essential role of angiotensin II receptor type 1a in recipient kidney, not in transplanted peripheral blood leukocytes, in progressive immune-mediated renal injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

The alpha8 integrin chain affords mechanical stability to the glomerular capillary tuft in hypertensive glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Effect of angiotensin II on hematopoietic progenitor cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021

A phage display screen and binding studies with acetylated low density lipoprotein provide evidence for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the ligand-binding function of MARCO.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.42

7 January 2021